• Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII

    Source: Nasdaq GlobeNewswire / 25 Jan 2023 07:03:00   America/Chicago

    N/A
Share on,